Policy | October 30, 2022
21.4 lakh TB cases notified in India in 2021
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
The company has reported total income of Rs. 3109.77 crores during the period ended September 30, 2022
The girl child anthem will portray a celebration of a girl child.
For the last ten financial years, the company has posted healthy performance with its revenue from operations growing at 15% CAGR and net profit at 23% CAGR
Xi Experience centre is aimed at familiarizing and bringing awareness about robotic-assisted surgery among the surgical fraternity in the country
The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine.
Cumulatively, almost 75% of the health centres in the country have been electrified with a cumulative solar capacity of 3.5 MW
The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries
Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg).
Subscribe To Our Newsletter & Stay Updated
